Trastuzumab Monotherapy Followed By the Combination of Trastuzumab and Letrozole in Post-Menopausal Women With ER-Positive, HER-2 Positive Advanced Breast Cancer Resistant to a Nonsteroidal Aromatase Inhibitor: A Multicenter Two-Step Phase II Trial.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Letrozole; Trastuzumab
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 15 May 2019 Biomarkers information updated
- 04 Jun 2012 Actual end date (1 Apr 2011) added as reported by ClinicalTrials.gov.
- 04 Jun 2012 Actual patient number 13 added as reported by ClinicalTrials.gov.